Marylou Cárdenas-Turanzas

Author

The University of Texas MD Anderson Cancer Center

Also Known As

M. Cárdenas-Turanzas, Marylou Cardenas-Turanzas, Marylou Cardenas‐Turanzas, Marylou Cárdenas-Turanzas, Marylou Cárdenas-Turanzas

Publications

2.6K

Citations

H-Index

Concepts

All Affiliations

The University of Texas MD Anderson Cancer Center The University of Texas Health Science Center at Houston Dongduk Women's University University of Alberta Ghent University

About

Marylou Cárdenas-Turanzas is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, oncology, and public health.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	17	19	998
2	Public Health	9	9	397
3	Health Sciences	6	6	266
4	Nursing	5	5	105
5	Social Sciences	1	1	12

Marylou Cárdenas-Turanzas

Publications

2.4K

Citations

H-Index

Page 1

	Year	Citations
Safety and activity of ibrutinib plus rituximab for patients with high-risk chronic lymphocytic leukaemia: a single-arm, phase 2 study Jan A. Burger, Michael J. Keating, William G. Wierda, The Lancet Oncology Hematological MalignancyLymphoid NeoplasiaOncologyImmunologyHematology	2014	330
Place of death in the population dying from diseases indicative of palliative care need: a cross-national population-level study in 14 countries Lara Pivodic, Koen Pardon, Lucas Morin, Journal of Epidemiology & Community Health	2015	207
Estimating the need for palliative care at the population level: A cross-national study in 12 countries Lucas Morin, Régis Aubry, Luisa Frova, Palliative Medicine	2016	172
International Variation in Place of Death of Older People Who Died From Dementia in 14 European and non-European Countries Thijs Reyniers, Luc Deliëns, H. Roeline W. Pasman, Journal of the American Medical Directors Association Alzheimer's DiseaseAgingGeriatricsGlobal HealthDementia	2014	134
Early responses predict better outcomes in patients with newly diagnosed chronic myeloid leukemia: results with four tyrosine kinase inhibitor modalities Preetesh Jain, Hagop M. Kantarjian, Aziz Nazha, Blood	2013	134
Accuracy of Colposcopy in the Diagnostic Setting Compared With the Screening Setting Scott B. Cantor, Marylou Cárdenas-Turanzas, Dennis D. Cox, Obstetrics and Gynecology	2008	83
Hematopoietic Cell Transplantation–Specific Comorbidity Index Predicts Inpatient Mortality and Survival in Patients Who Received Allogeneic Transplantation Admitted to the Intensive Care Unit Ulas D. Bayraktar, Elizabeth J. Shpall, Ping Liu, Journal of Clinical Oncology	2013	83
Prevalence and charges of opioid-related visits to U.S. emergency departments James R. Langabeer, Angela L. Stotts, Bentley J. Bobrow, Drug and Alcohol Dependence Opioid EpidemicSubstance AbuseHarm ReductionSubstance UseHealth Policy	2021	70
Cross-validation of a Sequential Organ Failure Assessment score–based model to predict mortality in patients with cancer admitted to the intensive care unit Marylou Cárdenas-Turanzas, Joe Ensor, Chris Wakefield, Journal of Critical Care Critical Care ManagementPrognostic AssessmentCritical Care MedicinePrognostic EvaluationIntensive Care Unit	2012	65
A Prognostic Model of Therapy-Related Myelodysplastic Syndrome for Predicting Survival and Transformation to Acute Myeloid Leukemia Alfonso Quintás‐Cardama, Naval Daver, Hawk Kim, Clinical Lymphoma Myeloma & Leukemia Hematological MalignancyOncologyMixed-phenotype Acute LeukemiaAcute Myeloid LeukemiaPrognosis	2014	65

Page 1